Alimera Sciences reported $-5257000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Alimera Sciences ALIM:US USD -5257000 2.14M
Bayer BAYN:GR EUR 546M 844M
Insmed INSM:US USD -131145000 35.5M
Novartis NOVN:VX USD 1.57B 121M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Roche Holding ROG:VX 8.53B 2.4B